Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-cash Items: 2020-2024

Historic Non-cash Items for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $6.2 billion.

  • Journey Medical's Non-cash Items fell 47.98% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 47.98%. This contributed to the annual value of $6.2 billion for FY2024, which is 79.94% up from last year.
  • Per Journey Medical's latest filing, its Non-cash Items stood at $6.2 billion for FY2024, which was up 79.94% from $3.4 billion recorded in FY2023.
  • In the past 5 years, Journey Medical's Non-cash Items ranged from a high of $9.7 billion in FY2021 and a low of $7.9 million during FY2020.
  • For the 3-year period, Journey Medical's Non-cash Items averaged around $4.0 billion, with its median value being $3.4 billion (2023).
  • Its Non-cash Items has fluctuated over the past 5 years, first surged by 121,667.12% in 2021, then tumbled by 77.04% in 2022.
  • MRY analysis of 5 years shows Journey Medical's Non-cash Items stood at $7.9 million in 2020, then surged by 121,667.12% to $9.7 billion in 2021, then crashed by 77.04% to $2.2 billion in 2022, then soared by 55.16% to $3.4 billion in 2023, then surged by 79.94% to $6.2 billion in 2024.
  • Its last three reported values are $6.2 billion in FY2024, $3.4 billion for FY2023, and $2.2 billion during FY2022.